These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8574959)

  • 1. A lesson from the HIV patient: the immune response is still the bane (or promise) of gene therapy.
    Koenig S
    Nat Med; 1996 Feb; 2(2):165-7. PubMed ID: 8574959
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase I/II pilot study of the safety of the adoptive transfer of syngeneic gene-modified cytotoxic T lymphocytes in HIV-infected identical twins.
    Walker RE
    Hum Gene Ther; 1996 Feb; 7(3):367-400. PubMed ID: 8835223
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV infection and gene transfer therapy.
    Jolly DJ
    Hum Gene Ther; 1991; 2(2):111-2. PubMed ID: 1911930
    [No Abstract]   [Full Text] [Related]  

  • 4. Adoptive immunotherapy.
    Res Initiat Treat Action; 1999 Jan; 5(1):19. PubMed ID: 11366227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for AIDS.
    Anderson WF
    Hum Gene Ther; 1994 Feb; 5(2):149-50. PubMed ID: 8186295
    [No Abstract]   [Full Text] [Related]  

  • 6. T-cell therapy of cytomegalovirus and human immunodeficiency virus infection.
    Riddell SR; Greenberg PD
    J Antimicrob Chemother; 2000 Apr; 45 Suppl T3():35-43. PubMed ID: 10855770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ cytotoxic T cell therapy of cytomegalovirus and HIV infection.
    Riddell SR; Gilbert MJ; Greenberg PD
    Curr Opin Immunol; 1993 Aug; 5(4):484-91. PubMed ID: 8216922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients.
    Riddell SR; Elliott M; Lewinsohn DA; Gilbert MJ; Wilson L; Manley SA; Lupton SD; Overell RW; Reynolds TC; Corey L; Greenberg PD
    Nat Med; 1996 Feb; 2(2):216-23. PubMed ID: 8574968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I clinical trial to evaluate the safety and biological activity of HIV-IT (TAF) (HIV-1IIIBenv-transduced, autologous fibroblasts) in asymptomatic HIV-1 infected subjects.
    Galpin JE; Casciato DA; Richards SB
    Hum Gene Ther; 1994 Aug; 5(8):997-1017. PubMed ID: 7948149
    [No Abstract]   [Full Text] [Related]  

  • 10. Adoptive therapy with purified CD8 cells in HIV infection.
    Herberman RB
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):35-40. PubMed ID: 1535457
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune control of HIV-1 replication.
    Walker BD; Rosenberg ES; Hay CM; Basgoz N; Yang OO
    Adv Exp Med Biol; 1998; 452():159-67. PubMed ID: 9889969
    [No Abstract]   [Full Text] [Related]  

  • 12. Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism.
    van Kuyk R; Torbett BE; Gulizia RJ; Leath S; Mosier DE; Koenig S
    J Immunol; 1994 Nov; 153(10):4826-33. PubMed ID: 7963548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T lymphocytes in HIV-1 infection: a killing paradox?
    Klein MR; van der Burg SH; Pontesilli O; Miedema F
    Immunol Today; 1998 Jul; 19(7):317-24. PubMed ID: 9666605
    [No Abstract]   [Full Text] [Related]  

  • 14. Sometimes help may not be enough.
    Lederman MM; Douek DC
    AIDS; 2003 May; 17(8):1249-51. PubMed ID: 12819528
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance of HIV-infected cells to cytotoxic T lymphocytes.
    Collins KL
    Microbes Infect; 2004 Apr; 6(5):494-500. PubMed ID: 15109965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNA.
    Hofmann C; Harrer T; Kubesch V; Maurer K; Metzner KJ; Eismann K; Bergmann S; Schmitt-Haendle M; Schuler G; Dörrie J; Schaft N
    AIDS; 2008 Aug; 22(13):1577-82. PubMed ID: 18670216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for HIV infection.
    Lancet; 1993 Jan; 341(8838):171. PubMed ID: 8093761
    [No Abstract]   [Full Text] [Related]  

  • 18. Highly restricted T-cell receptor repertoire in the CD8+ T-cell response against an HIV-1 epitope with a stereotypic amino acid substitution.
    Miyazaki E; Kawana-Tachikawa A; Tomizawa M; Nunoya J; Odawara T; Fujii T; Shi Y; Gao GF; Iwamoto A
    AIDS; 2009 Mar; 23(6):651-60. PubMed ID: 19279440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired constitutive expression of interferon beta after gene transduction enhances human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity by a RANTES-dependent mechanism.
    Hadida F; De Maeyer E; Cremer I; Autran B; Baggiolini M; Debré P; Vieillard V
    Hum Gene Ther; 1999 Jul; 10(11):1803-10. PubMed ID: 10446920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering HIV-Specific Immunity with Chimeric Antigen Receptors.
    Kitchen SG; Zack JA
    AIDS Patient Care STDS; 2016 Dec; 30(12):556-561. PubMed ID: 27905838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.